ANI Pharmaceuticals, Inc.

8-K Director or officer change; Shareholder vote results May 21, 2026 8-K Regulation FD disclosure May 13, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 8, 2026 8-K Changed accountants Apr 7, 2026 8-K Regulation FD disclosure Mar 3, 2026 10-K Fiscal year ended 2025-12-31 Feb 27, 2026 8-K Results of operations (earnings release) Feb 27, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Director or officer change; Regulation FD disclosure Dec 1, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Nov 7, 2025 8-K Unregistered sale of equity; Modified rights of security holders Sep 26, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Sep 8, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release) Aug 8, 2025 8-K Other events Jul 29, 2025 8-K Other events Jul 23, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jul 23, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jun 4, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results May 23, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 20, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 9, 2025 8-K Other events May 8, 2025 8-K Other events Mar 18, 2025 8-K Other events Mar 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 11, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release) Feb 28, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release) Nov 8, 2024 8-K Entered a material agreement; Completed an acquisition or disposition Sep 20, 2024 8-K Other events Sep 16, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Aug 13, 2024 8-K Other events Aug 8, 2024